ClinVar Miner

Submissions for variant NM_000083.3(CLCN1):c.950G>A (p.Arg317Gln)

gnomAD frequency: 0.00001  dbSNP: rs80356702
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 12
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Athena Diagnostics Inc RCV000516960 SCV000612809 pathogenic not provided 2016-11-04 criteria provided, single submitter clinical testing
Centre for Mendelian Genomics, University Medical Centre Ljubljana RCV000626585 SCV000747286 likely pathogenic Migraine; Memory impairment; Muscle spasm; EMG: neuropathic changes; EMG: myotonic runs; Limb pain 2017-01-01 criteria provided, single submitter clinical testing
Fulgent Genetics, Fulgent Genetics RCV000763169 SCV000893758 pathogenic Congenital myotonia, autosomal recessive form; Congenital myotonia, autosomal dominant form 2018-10-31 criteria provided, single submitter clinical testing
Invitae RCV000763169 SCV000931840 pathogenic Congenital myotonia, autosomal recessive form; Congenital myotonia, autosomal dominant form 2023-09-03 criteria provided, single submitter clinical testing This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 317 of the CLCN1 protein (p.Arg317Gln). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with autosomal dominant and recessive myotonia congenita (PMID: 8533761, 10737121, 29606556; Invitae). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 17542). For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CLCN1 protein function. Experimental studies have shown that this missense change affects CLCN1 function (PMID: 8845168).
HudsonAlpha Institute for Biotechnology, HudsonAlpha Institute for Biotechnology RCV000019095 SCV001190886 likely pathogenic Congenital myotonia, autosomal dominant form 2019-08-26 criteria provided, single submitter research
Centre for Mendelian Genomics, University Medical Centre Ljubljana RCV000019094 SCV001369057 likely pathogenic Congenital myotonia, autosomal recessive form 2016-01-01 criteria provided, single submitter clinical testing This variant was classified as: Likely pathogenic. The following ACMG criteria were applied in classifying this variant: PS1,PP3,PP2.
GeneDx RCV000516960 SCV002044125 pathogenic not provided 2023-09-01 criteria provided, single submitter clinical testing Reported in the heterozygous state in several families, but also in the heterozygous and homozygous state in one family with myotonia congenita (Meyer-Kleine et al., 1995; Esteban et al., 1998), and not observed in homozygous state in controls; Published functional studies indicate that R317Q shifts the gating threshold to a positive voltage thus altering channel gating and preventing repolarization of the channel (Pusch et al., 1995); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 24349310, 25749817, 17395130, 12163078, 11933197, 15786415, 27415035, 9736777, 10737121, 8533761, 8845168, 34529042, 35907044)
OMIM RCV000019094 SCV000039382 pathogenic Congenital myotonia, autosomal recessive form 1998-03-01 no assertion criteria provided literature only
OMIM RCV000019095 SCV000039383 pathogenic Congenital myotonia, autosomal dominant form 1998-03-01 no assertion criteria provided literature only
GeneReviews RCV000020121 SCV000040441 not provided Batten-Turner congenital myopathy no assertion provided literature only
Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences RCV000019095 SCV002549792 pathogenic Congenital myotonia, autosomal dominant form 2022-04-06 no assertion criteria provided research
GenomeConnect - Invitae Patient Insights Network RCV000763169 SCV004228549 not provided Congenital myotonia, autosomal recessive form; Congenital myotonia, autosomal dominant form no assertion provided phenotyping only Variant interpreted as Pathogenic and reported on 05-01-2019 by Lab Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.